Buprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States?

In US office‐based medical practices, diagnoses for opioid use disorder (OUD) and buprenorphine prescriptions for adults with OUD increased from 0.14 and 56.1% in 2006–10 to 0.38 and 73.6% in 2011–15.

Link to Abstract

Expenditure on smoking and alternative nicotine delivery products: a population survey in England

In England, the average smoker may save an estimated £15.06 per week by switching completely to e‐cigs or £13.04 per week by switching to NRT.

Link to Abstract

Psychostimulant use and the brain

The major neuropsychiatric harms of psychostimulant use can lead to severe long‐term impairment and include stroke, neurocognitive impairment, Parkinson's disease, seizures and psychotic illness.

Link to Abstract